An Advanced Endoscopy Device for:Esophageal Mucosal Resection
Gastric Mucosal Resection
Colon Mucosal Resection
The EndoRotor®The EndoRotor® is a next generation interventional resection device designed to address challenges of incomplete resection and post endoscopic mucosal resection scarred lesions.
Current Event: Digestive Disease Week (DDW)Chicago, IL
May 6 – 9, 2017
The EndoRotor®: Completing Your Endoscopic Toolkit
CE Mark – Europe: The EndoRotor® is indicated for endoscopic resection of tissue from within the GI (gastrointestinal) tract.
FDA 510(k) – US: The EndoRotor® is intended for use in endoscopic procedures by a trained gastroenterologist to resect and remove residual tissue from the peripheral margins following EMR (Endoscopic Mucosal Resection). The EndoRotor should not be used for the primary resection of lesions or for tissue intended for biopsy.
The EndoRotor®, a 3-in-1 interventional tool, allows you to simultaneously dissect, resect and collect providing features that complement today’s GI toolkit.
The number one issue facing resection is the lack of precision, and completion of resection.
Meet the Interscope Management Team
Jeffery Ryan, Jr.
Co-Founder, President & CEO
Jeffery Ryan, Jr., has more than 12 years of marketing and sales experience in the medical device industry. Prior to Interscope, Mr. Ryan earned his experience with Medtronic Surgical Technologies and Smith and Nephew Orthopedics in direct sales with increasing leadership roles. He earned several high accolades including multiple Presidents Club Awards, Sales Excellence Awards and Top Graduate. Continue Reading →
Ramon A. Franco Jr., MD
Co-Founder, Chief Scientific Officer
Ramon A. Franco, Jr., MD, has been practicing Otolaryngologist specializing in Laryngology at Massachusetts Eye and Ear Infirmary in Boston, Massachusetts for the past 14 years. During the last 11 years Dr. Franco has been the Division Director for Laryngology where he is directly responsible for the management of a renowned fellowship program in addition to leading globally-recognized research. Continue Reading →
Director of Research and Development
Corey Libby leverages over 20 years experience in medical, consumer and industrial product development. Prior to Interscope, Mr. Libby held Director leadership roles in product development consultancies where he led the development of medical devices including surgical, robotic and imaging platforms for various stage partners. Continue Reading →
News & Events
Recent Press Releases
Interscope announces FDA Clearance of the EndoRotor®, the first Flexible Shaver Technology for Interventional Gastroenterology
Business Wire | May 2, 2017
“Worcester, Massachusetts, USA – Interscope, Inc. announced today the receipt of marketing clearance from the FDA for the EndoRotor® System in the USA to commercialize in gastroenterology and colorectal surgery. Clinical data shows that incomplete resection of colorectal disease is a challenge and rates of disease persistence are as high as 30 percent, leading to an increase in complications. Interscope innovated the first flexible microdebrider for use by medical specialists in the digestive tract to facilitate complete removal of diseased mucosa. Unlike existing instruments, the EndoRotor® performs tissue dissection, resection and retrieval in a single step enabling endoscopists to facilitate disease removal without thermal energy.”
Interscope wins CE Mark for EndoRotor® endoscopic resection device
MassDevice | March 10, 2016
“Worcester, Mass.-based medical device startup Interscope said today that it won CE Mark approval in the European Union for its EndoRotor endocopic resection tool designed to remove mucosal lesions and Barrett’s esophagus.
The company said the approval was possible due to support it received from the Massachusetts Manufacturing Extension Partnership, as well as the development effort with its resource partner Boston Engineering.
“Many young companies face business needs that are often not paired well with available resources. The partnership that MassMEP and Boston Engineering presented enabled a dream to take reality in a challenging and dynamic regulatory environment,” Interscope prez Jeffery Ryan said in prepared remarks.”
Worcester startup gets European medical device approval
WB Journal | March 10, 2016
“The Worcester-based medical device company Interscope has received European Union approval to market its endoscopic device, and the U.S. Patent Office awarded the company five patents.
The EU approval of the company’s EndoRotor System, an endoscopic device that streamlines interventional gastrointestinal procedures used manage colon and esophageal cancer, is a milestone for the company. But the news isn’t just good for the company, but also for the Worcester-based Massachusetts Manufacturing Extension Partnership (MassMEP), which supported the start-up and helped it bring its products to commercialization. Boston Engineering was also involved, driving the product development and design for manufacturing (DFM) process including feasibility and analysis; industrial design; rapid prototyping; and product engineering.”
Current and Upcoming Events
Endoskopie 2017 – April 6-8, 2017
Digestive Disease Week (DDW) – May 21-24, 2016
United European Gastroenterology (UEG) Week 2015 – October 24-28, 2015
Digestive Disease Week (DDW) – May 16-19, 2015
“The EndoRotor® is an exciting invention that would be easier and safer than hot biopsy or snare for flat polyp removal when piecemeal removal is necessary. This may be useful for clean up after piecemeal polypectomy or in replacement for cold snare polypectomy.”
– Norio Fukami, MD., Associate Professor University of Colorado
“The EndoRotor® is a revolutionary new tool in the endoscopists toolkit that promises to help resect difficult polyps in a safe and efficient manner.”
– Sushil Duddempudi, MD., Director of Interventional Endoscopy, The Brooklyn Hospital Center
“The EndoRotor® builds on a smart and simple idea that has been used outside the GI tract. It has great potential to simplify resection of small mucosal lesions in the upper and lower GI tract, may aid mucosal resection of large lesions, and studies on technical feasibility and safety in humans are eagerly awaited.”
– Heiko Pohl, MD., Assistant Professor of Gastroenterology, Dartmouth-Hitchcock Medical Center
Director of Endoscopy, White River Junction VA Hospital